Self-consistent gradient flow for shape optimization

par Kraft, D.
Publié dans Optim Methods Softw (2017)

The relationship of HNK-1 (Leu 7) and VEP13 antigens on human cells mediating natural killing.

par Rumpold, H, Kraft, D, Gastl, G, Huber, C
Publié 1984

Characterization of a birch pollen allergen, Bet v III, representing a novel class of Ca2+ binding proteins: specific expression in mature pollen and dependence of patients' IgE bi...

par Seiberler, S, Scheiner, O, Kraft, D, Lonsdale, D, Valenta, R
Publié 1994

Immunoglobulin E antibodies of atopic individuals exhibit a broad usage of V(H)-gene families

par Eibensteiner, P, Spitzauer, S, Steinberger, P, Kraft, D, Valenta, R
Publié 2000

Immunohistologic identification of Aspergillus spp. and other hyaline fungi by using polyclonal fluorescent antibodies.

par Kaufman, L, Standard, P G, Jalbert, M, Kraft, D E
Publié 1997

Salmonella in Wastes Produced at Commercial Poultry Farms

par Kraft, D. J., Olechowski-Gerhardt, Carolyn, Berkowitz, J., Finstein, M. S.
Publié 1969

A monoclonal antibody (VEP10) against an antigen shared by human large granular lymphocytes, thymocytes and activated T cells.

par Rumpold, H, Kraft, D, Obexer, G, Böck, G, Möschl, P
Publié 1983

Lack of evidence for IgM-induced ADCC: studies with monoclonal and polyclonal antibodies.

par Rumpold, H, Wiedermann, G, Scheiner, O, Kraft, D, Stemberger, H
Publié 1981

Journal selection decisions: a biomedical library operations research model. I. The framework.

par Kraft, D H, Polacsek, R A, Soergel, L, Burns, K, Klair, A
Publié 1976

Squamous cell carcinoma: infiltrating monocyte/macrophage subpopulations express functional mature phenotype.

par Neuchrist, C., Grasl, M., Scheiner, O., Lassmann, H., Ehrenberger, K., Kraft, D.
Publié 1990

The Fate of a Normal Human Cell Traversed by a Single Charged Particle

par Fournier, C., Zahnreich, S., Kraft, D., Friedrich, T., Voss, K.-O., Durante, M., Ritter, S.
Publié 2012

IgE responses to exogenous and endogenous allergens in atopic dermatitis patients under long‐term systemic cyclosporine A treatment

par Lucae, S., Schmid‐Grendelmeier, P., Wüthrich, B., Kraft, D., Valenta, R., Linhart, B.
Publié dans Allergy (2015)

The use of VEP13 monoclonal antibody for definition of natural killer cells: spontaneous killer cells directed against fresh human leukaemia cells carry the VEP13 antigen.

par Ziegler-Heitbrock, H W, Fütterer, A, Rumpold, H, Kraft, D, Munker, R, Riethmüller, G
Publié 1984

Hydrocortisone enhances total IgE levels--but not the synthesis of allergen-specific IgE--in a monocyte-dependent manner.

par Bohle, B, Willheim, M, Baier, K, Stadler, B, Spitzauer, S, Scheiner, O, Kraft, D, Ebner, C
Publié 1995

Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen alle...

par Wiedermann, U, Jahn-Schmid, B, Fritsch, R, Bauer, L, Renz, H, Kraft, D, Ebner, C
Publié 1998

The gene coding for the major birch pollen allergen Betv1, is highly homologous to a pea disease resistance response gene.

par Breiteneder, H, Pettenburger, K, Bito, A, Valenta, R, Kraft, D, Rumpold, H, Scheiner, O, Breitenbach, M
Publié 1989

Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1

par BAUER, L, BOHLE, B, JAHN-SCHMID, B, WIEDERMANN, U, DASER, A, RENZ, H, KRAFT, D, EBNER, C
Publié 1997

IgA autoreactivity: a feature common to inflammatory bowel and connective tissue diseases

par KAZEMI-SHIRAZI, L, GASCHE, C H, NATTER, S, GANGL, A, SMOLEN, J, SPITZAUER, S, VALENT, P, KRAFT, D, VALENTA, R
Publié 2002

Induction of mucosal tolerance with recombinant Hev b 1 and recombinant Hev b 3 for prevention of latex allergy in BALB/c mice

par HUFNAGL, K, WAGNER, B, WINKLER, B, BAIER, K, HOCHREITER, R, THALHAMER, J, KRAFT, D, SCHEINER, O, BREITENEDER, H, WIEDERMANN, U
Publié 2003

Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy.

par Vrtala, S, Hirtenlehner, K, Vangelista, L, Pastore, A, Eichler, H G, Sperr, W R, Valent, P, Ebner, C, Kraft, D, Valenta, R
Publié 1997